Log in
Cardiff University, through developing and patenting a commercially viable synthetic route to a catalyst, has enabled the application of a new process, the Alpha Process, for the production of methyl methacrylate (MMA), a key commodity precursor to Perspex. The Alpha Process has had economic and environmental impacts.
Lucite International, the world's leading MMA producer, has invested in major Alpha Process production facilities in Singapore and Saudi Arabia, benefitting from a production route which is more efficient, more reliable and cheaper than conventional routes.
The Alpha Process also brings environmental benefits, as it does not rely on the use of corrosive and toxic feedstocks, such as hydrogen cyanide, which are associated with conventional MMA processes.
The growth and performance of Biofocus Galapagos Argenta (BGA) and Pulmagen Therapeutics (PT) are underpinned by research from the Imperial-based TeknoMed project that started in 1997. BGA was formed in 2010 through the acquisition of Argenta Discovery (AD) by Biofocus Galapagos for €16.5 million and is one of the world's largest drug discovery service organisations with 390 plus employees and turnover of €135 million [section 5, A]. PT was formed as a separate company to own the complete AD drug pipeline. It develops new medicines to treat asthma, cystic fibrosis and allergic diseases. In 2011 BGA signed agreements with PT for an initial £6million fee and with Genentech for £21.5million.
The cost of goods is an especially important issue in developing commercially available agrochemicals, which must be manufactured on a large scale. Richard Compton's research at the University of Oxford has led to a step change in the understanding of heterogeneous reaction mechanisms for liquid — organic solid or liquid — inorganic solid processes involved in large-scale manufacturing processes. Compton's work has had particular impact on optimising the processes used by Syngenta AG in its manufacturing of agrochemicals. Since 2008 the insights gained on inorganic-base dissolution have been of great benefit to Syngenta in its development of scalable robust manufacturing processes, particularly in relation to production of its fungicide Amistar and insecticide Actara, which are two of the world's largest selling products of this type. In 2012 Syngenta achieved total sales of over $ 14 billion, $ 4.8 billion of this from fungicide and insecticide revenues.
Many clinically-useful natural products fall into the class of polyketides. From 1993, research led by Professors Leadlay (Biochemistry) and Staunton (Chemistry) on polyketide biosynthesis pathways led to the foundation of the spin-out company Biotica Technology Ltd in 1996. Between 2008 and 2013 the company provided continuous employment for on average 15-20 highly-skilled scientists, and attracted additional investments of £4.43M. Its follow-on company Isomerase Therapeutics Ltd, founded by ex-Biotica researchers with Leadlay's support in 2013, has acquired compounds, strains and IP from Biotica. Using the methods developed in the University by Leadlay and Staunton, Biotica developed a HepC antiviral therapy, sold in 2013 to NeuroVive Pharmaceuticals AB and currently entering pre-clinical toxicology tests. Biotica have also licensed their technology to a number of companies globally, including GSK and Amyris.
UCL research has been instrumental in creating critically needed new biocatalysts and bioprocess technologies for industrial biocatalytic process development. These have impact across the UK chemical and pharmaceutical sectors. BiCE enzyme technologies have been exploited through the formation of a spin-out company, Synthace, generating investment of £1.8m and creation of 7 new jobs. Commercial utilisation of BiCE enzymes by company partners has led to environmental benefits through sustainable syntheses and reduced waste generation. BiCE high-throughput bioprocess technologies have also been adopted to speed biocatalytic process development. UCL established a parallel miniature stirred bioreactor system as a new product line for HEL Ltd. [text removed for publication]. Related knowledge transfer activities have also benefited some 157 industrial employees from over 50 companies since 2008.
Catalysis is a major UK industry strength and wealth generator for the UK economy. Research carried out in the group of Professor Matthew Davidson in the Department of Chemistry at the University of Bath resulted in the development of titanium and zirconium alkoxide catalysts for use in three industrial polymerisation processes and patented by the UK companies ICI Synetix and Johnson Matthey. Patents have recently also been acquired by the Indian multinational Dorf Ketal and filed by the Dutch multinational Corbion Purac. The research has resulted in the adoption of new catalysts in industry leading to increased turnover, onward dissemination and implementation of the Bath intellectual property. It has also generated £4.6M from sale of intellectual property and an increase in generated sales of new, sustainable titanium catalysts that replace heavy metals such as tin, antimony and mercury in major industrial processes. The intellectual property and process developments have been implemented globally in the poly(ethylene terephthalate) (PET) and poly(urethane) (PU) plastics markets, worth $23B and $33B, respectively, in 2010.
University of Nottingham researchers have been at the forefront in promoting and establishing Green Chemistry in developing nations. Working with and influencing colleagues and policymakers in both the UK and Africa, they have increased awareness of the importance of introducing sustainable technologies that meet local communities' needs. As a result, they have invigorated the chemistry teaching curriculum in Ethiopia, placing Green Chemistry at its core, and helped shape the approaches of professional bodies, including the Royal Society of Chemistry, for the benefit of the developing world. This has led to what the British Council has described as "a sense of empowerment and confidence" among Ethiopian chemists.
The pioneering work of Steven Ley on polymer-supported reagents and continuous-flow reaction technology has helped change the way we achieve cleaner chemical processes. The concepts and techniques invented in Cambridge allow more sustainable processes to be developed, with concomitant reduction in purification steps, shorter reaction times and diminished solvent usage. The work has led to a spin-out company (Reaxa), seeded the creation of a number of other companies, and resulted in the development of several devices for continuous flow synthesis that are now commercially available via Mettler-Toledo (USA) and Cambridge Reactor Design (UK). This technology is having an impact in industry, with continuous flow processing increasingly being used for full-scale commercial production.
Through research carried out under an EPSRC Teaching Company (KTP) award, we assisted an SME, CellPath, to develop the capacity to manufacture a novel set of dyes (Ortho Stains) for use in the Papanicolaou cervical smear test and other histological procedures. The company, previously mainly known for manufacture and sales of laboratory plastics etc, rapidly become the UK market leader in cytology stains, with over 50% of the domestic market, and exports to Finland, France, Italy, Japan, Norway, Sweden and the USA. As a result the company has increased turnover by 400% and the workforce has grown from 5 to 65 employees.
The School of Chemistry has a long track record of pioneering and innovative outreach activities aimed at stimulating public interest and understanding in chemistry research and its societal impact. During the period 2008-2013 it successfully communicated to a wide-ranging audience the significance of a series of "firsts" in the areas of nanoscience and materials for energy applications. Using YouTube, Royal Society Summer Science Exhibitions, roadshows and science festivals, this award-winning approach has engaged hundreds of thousands through digital media and thousands more face-to-face, raising public awareness, inspiring interest in science and delivering educational benefits for students and teachers alike.